Landmark Properties and Manulife Investment Management Announce Construction Start on The Metropolitan on South U in Ann Arbor, MI

950+ Bed Student Housing Community Adjacent to the University of Michigan's Campus Landmark Properties, a fully-integrated real estate firm specializing in development, construction, investment management, and operation of high-quality residential communities, has partnered with Manulife Investment Management (Manulife IM) to construct The Metropolitan on South U, a 259-unit student housing community at 1208 South University […]

PANTHERx® Rare Selected by Otsuka to Dispense VOYXACT® (sibeprenlimab-szsi) for the Treatment of Primary Immunoglobulin A Nephropathy

PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, announced that it was selected by Otsuka as the exclusive specialty pharmacy to dispense VOYXACT®, an APRIL (A Proliferation Inducing Ligand) blocker, indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk

Financial Compass Group Celebrates 20 Years of Financial Guidance Driven by Purpose

Wellesley Hills, Massachusetts, Dec. 18, 2025 (GLOBE NEWSWIRE) — Financial Compass Group, LLC (Source: Financial Compass Group, LLC) Financial Compass Group, LLC is commemorating 20 years of serving business owners, individuals, and families with a thoughtful, planning-centered approach to financial decision-making. Since its founding, the firm has focused on helping clients bring structure and clarity

Biofrontera Inc. Completes Transfer of Ameluz(R) and RhodoLED(R) FDA approval and Associated Intellectual Property Portfolio

(NASDAQ:BFRI),(NASDAQ:BFRIW), • Ameluz(R) and RhodoLED(R) New Drug Application (NDA) and Investigational New Drug Application (IND) have successfully been transferred to Biofrontera Inc.• Assignment to Biofrontera Inc. of 11 granted US patents, 10 pending US patent applications and various trademarks associated with Ameluz(R) and the RhodoLED(R) Lamp Series has been applied for registration with the relevant

One and One Green Technologies Secures $7.7 Million in Contracts for Recycled Metal Products in November 2025

(NASDAQ:YDDL), Wins Orders for Copper Alloy Ingots and Aluminum Products, Demonstrating Strong Market Demand in the Asia-Pacific Region San Rafael, Bulacan, Philippines, Dec. 18, 2025 (GLOBE NEWSWIRE) — One and one Green Technologies. INC (“One and one” or the “Company”) (NASDAQ: YDDL), a Philippines-based recycler holding a government-issued license to import and process hazardous waste

Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants

(TSX-V:CNVI),(OTC US:CNVIF),(Other OTC:CNVIF), NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Company“), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies

Actuate Therapeutics Phase 2 Metastatic Pancreatic Cancer Data Selected for Oral and Poster Presentation at ASCO GI 2026

(NasdaqGM:ACTU), CHICAGO and FORT WORTH, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3B (GSK-3B), today announced that data from its Phase 2 study evaluating elraglusib

Biofrontera Inc. Completes Transfer of Ameluz(R) and RhodoLED(R) FDA approval and Associated Intellectual Property Portfolio

Biofrontera Inc. Completes Transfer of Ameluz(R) and RhodoLED(R) FDA approval and Associated Intellectual Property Portfolio GlobeNewswire December 18, 2025 • Ameluz(R) and RhodoLED(R) New Drug Application (NDA) and Investigational New Drug Application (IND) have successfully been transferred to Biofrontera Inc.• Assignment to Biofrontera Inc. of 11 granted US patents, 10 pending US patent applications and

One and One Green Technologies Secures $7.7 Million in Contracts for Recycled Metal Products in November 2025

One and One Green Technologies Secures $7.7 Million in Contracts for Recycled Metal Products in November 2025 GlobeNewswire December 18, 2025 Wins Orders for Copper Alloy Ingots and Aluminum Products, Demonstrating Strong Market Demand in the Asia-Pacific Region San Rafael, Bulacan, Philippines, Dec. 18, 2025 (GLOBE NEWSWIRE) — One and one Green Technologies. INC (“One

Scroll to Top